Published in Health and Medicine Week, February 27th, 2006
"The major sources of human exposure to NO are medicinal nitrovasodilators that release NO into the vasculature. NO-donating aspirin also releases NO in a similar manner, and is a potent in vitro inhibitor of colon cancer. The effects of nitrovasodilators on the risk of colorectal cancer was studied in the Framingham Heart and Offspring studies among 145 cases of colorectal cancer and 433 matched controls," scientists writing in the journal Anticancer Research reported.
"Eleven percent of controls reported currently using nitroglycerine or other long-lasting nitrates. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.